FISH for Bcl-6 Gene Rearrangement

FISH for Bcl-6 Gene Rearrangement

Bcl-6 (B-cell lymphoma 6) is a gene implicated in the normal development and function of B cells, which are a type of white blood cell involved in the immune response. Bcl-6 acts as a transcriptional repressor, modulating gene expression and assisting in the development and activation of B cells. However, abnormal rearrangement of this gene can be implicated in certain types of lymphomas, especially diffuse large B-cell lymphomas (DLBCL).

The Fluorescence In Situ Hybridization (FISH) test for Bcl-6 gene rearrangement is a sensitive and specific laboratory test that can identify genetic alterations of the Bcl-6 gene. FISH uses fluorescent probes that bind to specific areas of interest within the DNA, allowing abnormalities to be visualized under a fluorescent microscope.

  • Test NameFISH for Bcl-6 Gene Rearrangement
  • Sample TypeBlood / bone marrow
  • Preparations RequiredThere are no specific instructions for the patient prior to the test. However, patients should follow the doctor's or laboratory's instructions if given any.
  • Report Time5 days

What is the FISH test for Bcl-6 gene rearrangement?

The FISH test for Bcl-6 gene rearrangement is a sophisticated lab procedure that detects rearrangements of the Bcl-6 gene. These rearrangements can be associated with certain types of lymphomas, particularly diffuse large B-cell lymphomas.

Why is the detection of Bcl-6 gene rearrangement significant?

Detecting Bcl-6 gene rearrangement is important as it can provide critical information regarding diagnosis, prognosis, and treatment choices in cases of diffuse large B-cell lymphomas and other malignancies.

Home Sample Collection Process
Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The test is conducted on a blood or tissue sample. The sample is exposed to fluorescent probes that bind to the Bcl-6 gene, and any gene rearrangements are visualized under a fluorescence microscope.

A positive result signifies the presence of a Bcl-6 gene rearrangement, which may indicate that the patient has a type of lymphoma or other malignancy in which this rearrangement is common. This result can influence the diagnosis, prognosis, and therapeutic choices for the patient.

The test is usually recommended for individuals diagnosed with diffuse large B-cell lymphoma or who present symptoms indicative of this disease. The test may also be useful in monitoring disease progression and treatment effectiveness.

Understanding the status of Bcl-6 gene rearrangement can guide therapeutic strategies. Certain targeted therapies may be more effective in patients with specific gene rearrangements.

The risks are minimal and are generally related to the collection of the blood or tissue sample. There might be slight pain, bleeding, or bruising at the site of sample collection.

The frequency of testing depends on several factors, including the type and stage of lymphoma and the patient's response to treatment. Your doctor will provide guidance on how often this test needs to be done.

Technical issues such as poor sample quality or probe issues can affect the results. Hence, it is important that the test is conducted in a specialized laboratory with experienced personnel.

If there is a Bcl-6 gene rearrangement, it is advisable to consult an oncologist specializing in the treatment of lymphoma and other cancers.

The success of the treatment varies depending on various factors including the type of lymphoma, stage, and overall health of the patient. Treatment may include chemotherapy, targeted therapy, and stem cell transplant.

Yes, there are targeted therapies that inhibit or modulate the function of the Bcl-6 protein. These therapies are used in the treatment of certain lymphomas associated with Bcl-6 rearrangements.

Patients should discuss the results with their doctor to understand what they mean and how they can influence treatment decisions.

While the test is highly accurate, it is usually considered alongside other diagnostic tests and clinical information for a comprehensive evaluation.

The FISH test for Bcl-6 gene rearrangement is considered highly reliable when conducted in an experienced laboratory. However, it’s important to interpret the results in the context of the overall clinical picture.

The status of the Bcl-6 gene can be an important component in the diagnosis and management of certain lymphomas. The FISH test for Bcl-6 gene rearrangement is a valuable tool in guiding the therapeutic strategies and monitoring response to treatment. It’s important to communicate with your doctor to understand the implications of the test results and the available options for management and therapy.

FISH for BCl 6 Gene rearrangement
₹ 4500
Book Your Slot
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet